Summary
Overview
Work History
Education
Skills
Publications
Timeline
Generic

RICHARD KATZ, MD

Myerstown,PA

Summary

Results-oriented Matrix Leader with 15+ years of experience spearheading clinical-stage programs in cell therapy, biologics, neuroscience, immunotherapy, hematology, and oncology. Proven expertise in medical affairs planning, budgeting, cross-functional alignment, real-world evidence (RWE) generation, and key opinion leader (KOL) engagement. Committed to improving patient health outcomes, optimizing innovation, and enhancing research/clinical trial efficiency.

Overview

16
16
years of professional experience

Work History

Associate Director, Medical and Scientific Affairs

B. Braun Medical, Inc. / Aesculap Biologics, LLC
2019.11 - Current
  • Leadership: Lead, mentor, and coach clinical team
  • Enhance medical affairs infrastructure and program operations.
  • Drug Product Lead: Collaborate with cross-functional teams to align processes, regulatory strategy, and product development plans.
  • Regulatory Affairs: Oversee BLA initiative, preparing clinical/CMC sections and serving as clinical representative in regulatory communications.
  • Relationship Management: Build relationships with key stakeholders in Supply Chain, Manufacturing, Launch Excellence, Quality, Procurement, and Regulatory.
  • Clinical Operations: Develop and implement strategies, manage research staff, ensure compliance and quality standards, and manage clinical trial budgets exceeding $1M.
  • KOL Engagement: Engage with key opinion leaders, academic thought leaders, and clinical stakeholders.
  • Vendor Management: Negotiate and establish contracts with CROs.

Global Clinical Submission Quality Lead (Contract)

Synectics, Inc.
2019.07
  • Clinical Data Review: Ensured clinical data accuracy and completeness for global regulatory submissions (NDA, BLA).
  • Project Leadership: Member of Submission Integrated Process Leadership Team for XALKORI, BAVENCIO.

Pharmaceutical Regulatory Consultant

Cello Health (Innovative Science Solutions)
2018.07 - 2019.07
  • Regulatory Strategy: Developed and executed regulatory strategies for TECENTRIQ (breast cancer, lung cancer) and Opill (oral contraceptive).
  • Advisory Committee Support: Supported Oncologic Drugs Advisory Committee Meeting preparation for breast cancer treatment.

Medical Consultant

VIVO Agency
2018.10 - 2019.12
  • Product Launch: Supported global launch and development of new cardiovascular and orthopedic medical devices for Life Science companies.

Medical Advisory

Lehigh Valley Health Network
2008.01 - 2018.01
  • Academic-industry collaboration: Fostered collaborations between biopharma, PIs, and KOLs.
  • Clinical Trials: Conducted Phase II-IV CNS trials and outcomes-based research.
  • Neuromarker Research: Evaluated neuromarkers for various neurological conditions.
  • Scientific Publication Development: Provided expertise on regulatory compliance and industry standards for scientific publications.

Education

MD -

Université El Hadji Ibrahima Niasse (UEIN)
01.2004

Fellowship - Neuroscience -

Weill Medical College of Cornell University
01.2007

NIMH - Geriatric Translational Research Institute -

University of Pittsburgh

Skills

  • Clinical Trials Expertise: Phase II-IV design & execution, GCP adherence, outcomes-based research, compliance monitoring, CAPA implementation
  • Project & Scientific Oversight: Strategic leadership of study teams, vendor management, document development, regulatory timeline management, FDA/Health Canada communication
  • Medical Affairs Leadership: Build strategic partnerships with centers of excellence, KOLs, patient advocacy groups, managed care organizations, government programs, regulatory bodies, and cross-functional teams
  • Medical Writing: Development of clinical protocols, study reports, investigator brochures, publications (e.g., white papers on Negative Pressure Wound Therapy [NPWT] and health economics and outcomes research [HEOR])
  • Data Analysis & Interpretation: Expertise in analyzing and interpreting clinical trial data (including RWE/RWD) to inform targeted asset strategies and address regulatory demands
  • Proficient in Microsoft Office Suite
  • Electronic data capture (EDC) systems
  • Statistical software (e.g., SPSS, SAS)

Publications

  • Alexopoulos GS, Kanellopoulos D, Murphy CF, Gunning-Dixon F, Katz R, Heo M: Placebo Response: Does It Predict Antidepressant Response of Geriatric Depression? Am J Geriatr Psychiatry. 2007 Feb 15 (2): 149-58.
  • Alexopoulos GS, Kanellopoulos D, Murphy CF, Gunning-Dixon F, Katz R, Foxe JJ: Electrophysiological Responses to an Emotional Go/No-Go Test and Remission of Geriatric Depression. Neuroreport. 2007 Feb 12:18(3): 217-21.
  • De Sanctis PF, Katz R, Wylie GR, Alexopoulos GS, Foxe JJ: Enhancement and bi-lateralization of early sensory processing in the ventral visual stream may be a feature of normal aging: A high-density electrical mapping study. Neurobiology of Aging doi:10.1016/j.neurobiolaging.2007.03.021
  • Katz R, De Sanctis PF, Sehatpour P, Mahoney, Gomez MR, Murphy CF, Alexopoulos GS, Foxe JJ. Cognitive Control in Late-Life Depression: Response inhibition deficits and dysfunction of the Anterior Cingulate Cortex. The American Journal of Geriatric Psychiatry, 11 March 2010 doi: 10.1097/JGP.0b013e3181d695f2

Timeline

Associate Director, Medical and Scientific Affairs

B. Braun Medical, Inc. / Aesculap Biologics, LLC
2019.11 - Current

Global Clinical Submission Quality Lead (Contract)

Synectics, Inc.
2019.07

Medical Consultant

VIVO Agency
2018.10 - 2019.12

Pharmaceutical Regulatory Consultant

Cello Health (Innovative Science Solutions)
2018.07 - 2019.07

Medical Advisory

Lehigh Valley Health Network
2008.01 - 2018.01

MD -

Université El Hadji Ibrahima Niasse (UEIN)

Fellowship - Neuroscience -

Weill Medical College of Cornell University

NIMH - Geriatric Translational Research Institute -

University of Pittsburgh
RICHARD KATZ, MD